暗記メーカー

暗記メーカー

​
ログイン
Drugs acting on the central nercous sytem
37問 • 1年前
  • Hannah Angelique Losaria
    • 通報

    問題一覧

  • 1

    *key to neurophysiology *dependent upon: -concentration gradient - electrical gradients *modified by: -Gated ion channels

    ion diffusion

  • 2

    *decreased propagation of action potentials *Decrease Na+, Ca++ influx (delay depolarization, prolong repolarization) *increase Cl- influx (hyperpolarized membrane)

    anti seizure medications

  • 3

    Tonic-clonic and partial seizure drugs

    carbamazepine, lamotrigine, phenyoin, valproic acid

  • 4

    Absence seizure drugs

    clonazzepam, ethosuximide,, valproic acid

  • 5

    valium

    benzodiazepam

  • 6

    versed

    midazolam

  • 7

    xanax

    alprazolam

  • 8

    ativan

    lorazepam

  • 9

    Halcion

    triazolam

  • 10

    non benzo-benzo

    zolpidem, buspirone

  • 11

    ultra short acting barbiturate

    thiopental

  • 12

    indication of ultra short acting barbiturate

    anesthesia

  • 13

    typical indication of thiopental

    anesthesia

  • 14

    short acting barbiturate

    all

  • 15

    thiopental is

    ultrashort acting

  • 16

    amobarbital is

    short acting

  • 17

    pentobarbital is

    short acting

  • 18

    secobarbital is

    short acting

  • 19

    seconal is

    short acting

  • 20

    indication of short acting bbarbiturate

    insomnia

  • 21

    long acting barbiturate

    phenobarbital

  • 22

    luminal

    phenobarbital

  • 23

    seconal

    secobarbital

  • 24

    indication of long acting barbiturate

    seizure

  • 25

    which of the ff is true for the goal or approach of anti seizure medication

    decrease sodium influx

  • 26

    which of the following is used for absence seizures which works by blocking calcium channels at thethalamus

    ethosuximide

  • 27

    a Na channel blocker, is used in tonic-clonic and partial seizure

    carbamazepine

  • 28

    beenzodiazepines increase the duration of GABA-mediated channel opening. Barbiturates increase the frequency of GABA-mediated channel opening

    both statements are false

  • 29

    which of the following is not an adverse effect of typical antipsychotics

    worening of positive symptoms

  • 30

    less positive symptoms (addresses hallucinations)

    mesolimbic

  • 31

    worsening of negative symptoms, such as depression

    mesocortical

  • 32

    extrapyramidal symptoms, dyskenesia, akathasia, parkinsonism

    nigrostrial pathway

  • 33

    hyperprolactinemia

    tuberoinfundibular pathway

  • 34

    it is a MAO-B selective inhibitor used to manage Parkinson's disease.

    selegiline

  • 35

    inhibits DOPA-decatboxylase in the periphery to prevent adverse effects

    carbidopa

  • 36

    inhibits catechol-o-methyltransferase

    entacapone and tolcapone

  • 37

    mao-b inhibitors

    selegiline and rasagiline

    • gastro

    gastro

    Hannah Angelique Losaria · 100問 · 2年前

    gastro

    gastro

    100問 • 2年前
    Hannah Angelique Losaria

    gastro m

    gastro m

    Hannah Angelique Losaria · 7問 · 2年前

    gastro m

    gastro m

    7問 • 2年前
    Hannah Angelique Losaria

    lab

    lab

    Hannah Angelique Losaria · 13問 · 2年前

    lab

    lab

    13問 • 2年前
    Hannah Angelique Losaria

    m2

    m2

    Hannah Angelique Losaria · 94問 · 2年前

    m2

    m2

    94問 • 2年前
    Hannah Angelique Losaria

    m1

    m1

    Hannah Angelique Losaria · 88問 · 2年前

    m1

    m1

    88問 • 2年前
    Hannah Angelique Losaria

    poisons

    poisons

    Hannah Angelique Losaria · 50問 · 1年前

    poisons

    poisons

    50問 • 1年前
    Hannah Angelique Losaria

    lec

    lec

    Hannah Angelique Losaria · 19問 · 1年前

    lec

    lec

    19問 • 1年前
    Hannah Angelique Losaria

    exam

    exam

    Hannah Angelique Losaria · 16問 · 1年前

    exam

    exam

    16問 • 1年前
    Hannah Angelique Losaria

    spec

    spec

    Hannah Angelique Losaria · 41問 · 1年前

    spec

    spec

    41問 • 1年前
    Hannah Angelique Losaria

    midterm

    midterm

    Hannah Angelique Losaria · 55問 · 1年前

    midterm

    midterm

    55問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    Hannah Angelique Losaria · 54問 · 1年前

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    54問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    Hannah Angelique Losaria · 29問 · 1年前

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    29問 • 1年前
    Hannah Angelique Losaria

    DDS

    DDS

    Hannah Angelique Losaria · 33問 · 1年前

    DDS

    DDS

    33問 • 1年前
    Hannah Angelique Losaria

    hallucinogens

    hallucinogens

    Hannah Angelique Losaria · 22問 · 1年前

    hallucinogens

    hallucinogens

    22問 • 1年前
    Hannah Angelique Losaria

    non volatile poisons

    non volatile poisons

    Hannah Angelique Losaria · 42問 · 1年前

    non volatile poisons

    non volatile poisons

    42問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 63問 · 1年前

    endterm

    endterm

    63問 • 1年前
    Hannah Angelique Losaria

    q3 endterm

    q3 endterm

    Hannah Angelique Losaria · 17問 · 1年前

    q3 endterm

    q3 endterm

    17問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019

    mockboard 2019

    Hannah Angelique Losaria · 65問 · 1年前

    mockboard 2019

    mockboard 2019

    65問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019 II

    mockboard 2019 II

    Hannah Angelique Losaria · 39問 · 1年前

    mockboard 2019 II

    mockboard 2019 II

    39問 • 1年前
    Hannah Angelique Losaria

    問題一覧

  • 1

    *key to neurophysiology *dependent upon: -concentration gradient - electrical gradients *modified by: -Gated ion channels

    ion diffusion

  • 2

    *decreased propagation of action potentials *Decrease Na+, Ca++ influx (delay depolarization, prolong repolarization) *increase Cl- influx (hyperpolarized membrane)

    anti seizure medications

  • 3

    Tonic-clonic and partial seizure drugs

    carbamazepine, lamotrigine, phenyoin, valproic acid

  • 4

    Absence seizure drugs

    clonazzepam, ethosuximide,, valproic acid

  • 5

    valium

    benzodiazepam

  • 6

    versed

    midazolam

  • 7

    xanax

    alprazolam

  • 8

    ativan

    lorazepam

  • 9

    Halcion

    triazolam

  • 10

    non benzo-benzo

    zolpidem, buspirone

  • 11

    ultra short acting barbiturate

    thiopental

  • 12

    indication of ultra short acting barbiturate

    anesthesia

  • 13

    typical indication of thiopental

    anesthesia

  • 14

    short acting barbiturate

    all

  • 15

    thiopental is

    ultrashort acting

  • 16

    amobarbital is

    short acting

  • 17

    pentobarbital is

    short acting

  • 18

    secobarbital is

    short acting

  • 19

    seconal is

    short acting

  • 20

    indication of short acting bbarbiturate

    insomnia

  • 21

    long acting barbiturate

    phenobarbital

  • 22

    luminal

    phenobarbital

  • 23

    seconal

    secobarbital

  • 24

    indication of long acting barbiturate

    seizure

  • 25

    which of the ff is true for the goal or approach of anti seizure medication

    decrease sodium influx

  • 26

    which of the following is used for absence seizures which works by blocking calcium channels at thethalamus

    ethosuximide

  • 27

    a Na channel blocker, is used in tonic-clonic and partial seizure

    carbamazepine

  • 28

    beenzodiazepines increase the duration of GABA-mediated channel opening. Barbiturates increase the frequency of GABA-mediated channel opening

    both statements are false

  • 29

    which of the following is not an adverse effect of typical antipsychotics

    worening of positive symptoms

  • 30

    less positive symptoms (addresses hallucinations)

    mesolimbic

  • 31

    worsening of negative symptoms, such as depression

    mesocortical

  • 32

    extrapyramidal symptoms, dyskenesia, akathasia, parkinsonism

    nigrostrial pathway

  • 33

    hyperprolactinemia

    tuberoinfundibular pathway

  • 34

    it is a MAO-B selective inhibitor used to manage Parkinson's disease.

    selegiline

  • 35

    inhibits DOPA-decatboxylase in the periphery to prevent adverse effects

    carbidopa

  • 36

    inhibits catechol-o-methyltransferase

    entacapone and tolcapone

  • 37

    mao-b inhibitors

    selegiline and rasagiline